Lung cancer surgery Market by Product [Surgical Instruments (Staplers, Forceps, Retractors, Rib Shears & Tissue Sealers, Trocar, Cutters, Clamps, Scissors, Elevators, Powered Surgical Equipment, and Other Hand Instruments), Monitoring & Visualizing Systems (Cameras & Video Support, Endoscopic Trocars with Optical Views, and Others), and Endo surgical Equipment], Surgery [Lobectomy, Bilobectomy, Pneumonectomy, Removing a section of lung (Wedge resection, Segmentectomy, and Sleeve resection), Removing lymph nodes, and Minimally Invasive Surgeries), End User (Hospitals, ASCs, Specialty Cancer Care Centers, and Others): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00027054 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global

The market crossed US$ 5.89 billion mark in 2022 and is expected to hit US$ 8.32 billion by 2030, recording a CAGR of 4.4% during the forecast period. 

Increasing incidences of lung cancer is expected to assist the overall market growth

According to the American Cancer Society, there were 228,820 new cases of lung cancer diagnosed and about 135,720 deaths due to lung cancer in 2020.  The global incidence of lung cancer is projected to increase by 25 million per annum by 2030. The increasing cases of lung cancer in the recent past has resulted the hospitals and specialty care centers purchasing surgical instruments and equipment related to lung cancer treatment from manufacturers such as Accuray Inc., AngioDynamics Inc., Ethicon US, LLC, Intuitive Surgical Inc., and Olympus Corporation. This has assisted the demand for lung cancer surgery in the recent past and is expected to continue a similar trend during the forecast period. Lobectomy held the largest share for treating early-stage lung cancer in 2022. However, minimally invasive surgeries is expected to grow at the highest CAGR over the forecast period. Owing to the post-operative side effects associated with open surgery/ lobectomy, lung cancer operations use minimally invasive surgery methods, wherein small incisions (cuts) and few stitches are needed.

Within the report, the market is segmented into product, surgery, end user, and geography. By product, the market is further segmented into surgical instruments, monitoring & visualizing systems, and endo surgical equipment. Surgical Instruments is again segmented staplers, forceps, retractors, rib shears & tissue sealers, trocar, cutters, clamps, scissors, elevators, powered surgical equipment, and other hand instruments. Based on the surgery, the market is segmented into lobectomy, bilobectomy, pneumonectomy, removing a section of lung, removing lymph nodes, and minimally invasive surgeries. Removing a section of lung can be further segmented into wedge resection, segmentectomy, and sleeve resection. Based on end user, the market is segmented into hospitals, ambulatory surgical centers (ASCs), specialty cancer care centers, and others. Geographically, the market is subsegmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

Get more information on this report :

Technological advancements to boost the markets growth

Owing to surge in the global prevalence of lung cancer, there has been a notable shift in consumers opting for technologically superior medical systems and solutions. Technological developments in lung cancer surgery treatment and rising consumer preference for minimally invasive surgeries would boost market growth. Advanced surgical equipment and devices offer ease in operation and better versatility in complex medical situations. The development of advanced radiation technologies, including intensity-modulated radiation therapy (IMRT), Image guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT) and proton beam therapy (PBT), has resulted in increasingly conformal radiation treatments. For instance, the da Vinci Surgical System enables surgeons to perform lung cancer operations easily through a few small incisions. These incisions are done through robotic instruments and a camera is inserted during the operation is conducted. The da Vinci System exhibits a magnified 3D HD vision system and special instruments that bend and rotate far greater than the human hand. These characteristics enable surgeons to operate with enhanced vision, precision, and control.   

Hospitals segment captured the largest share in 2022

The hospitals segment accounted for the largest share of the global lung cancer surgery market in 2022. According to the American Lung Association “State of Lung Cancer” report, nationally, 20.6% of lung cancer cases underwent surgery. For instance, Mayo Clinic thoracic surgeons perform more than 900 minimally invasive lung operations every year. Modern surgical treatment methods adopted by hospitals have higher success rates and improved outcomes, including reduced post-surgical pain, shorter hospital stays and fewer complications. On the other hand, specialty cancer care center segment is anticipated to witness the highest growth rate during the forecast period.

Recent strategic developments in lung cancer surgery market

The lung cancer surgery market has undergone several significant developments, and a few of these have been mentioned below:

  • In November 2021, Olympus, one of the global technology leaders in designing and delivering innovative services for medical and surgical procedures, announced the support for new lung cancer screening guidelines that opened more at-risk individuals to potentially life-saving scans. EBUS-TBNA (Endobronchial Ultrasound-guided Transbronchial Needle Aspiration) was a procedure used in the diagnosis and staging of lung cancer, allowing health physicians to visualize diseased tissue, lymph nodes or lesions beyond the walls of the airways.

The lung cancer surgery market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Accuray Inc., AngioDynamics Inc., Ethicon US, LLC, Intuitive Surgical Inc., Olympus Corporation, Teleflex Incorporated, KARL STORZ GmbH, Scanlan International Inc., Medtronic Plc., and Siemens Healthcare are among the prominent players operating in the market.

Target audience for the report:

  • Medical device manufacturers and suppliers
  • Cancer Research institutes, organizations, and consulting companies
  • Academic Institutes
  • Healthcare Providers
  • Surgical Instrument Distributors

Scope of the report:

In this report, the market has been segmented on the basis of:

  • Product:
    • Surgical Instruments
      • Staplers, Forceps
      • Retractors
      • Rib Shears & Tissue Sealers
      • Trocar
      • Cutters
      • Clamps
      • Scissors
      • Elevators
      • Powered Surgical Equipment
      • Other Hand Instruments
    • Monitoring & Visualizing Systems
      • Cameras & Video Support
      • Endoscopic Trocars with Optical Views
      • Others
    • Endo Surgical Equipment
  • Surgery:
    • Lobectomy
    • Bilobectomy
    • Pneumonectomy
    • Removing a section of lung
      • Wedge resection
      • Segmentectomy
      • Sleeve resection
    • Removing lymph nodes
    • Minimally Invasive Surgeries
  • End User:
    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • Specialty Cancer Care Centers
    • Others 
  • Region
    • North America
      • US
      • Canada
      • Mexico
    • Europe
    • Asia Pacific (APAC)
    • Middle East & Africa
    • South & Central America

Companies profiled:

    • Accuray Inc.
    • AngioDynamics Inc.
    • Ethicon US, LLC
    • Intuitive Surgical Inc.
    • Olympus Corporation
    • Teleflex Incorporated
    • KARL STORZ GmbH
    • Scanlan International Inc.
    • Medtronic Plc.
    • Siemens Healthcare
    • Other Market Participants

The List of Companies
- Accuray Inc.
- AngioDynamics Inc.
- Ethicon US, LLC
- Intuitive Surgical Inc.
- Olympus Corporation
- Teleflex Incorporated
- KARL STORZ GmbH
- Scanlan International Inc.
- Medtronic Plc.
- Siemens Healthcare
- Other Market Participants

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$1500
Site License
$2500
Enterprise License
$3500